tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market

CNS Pharmaceuticals (CNSP) Financial Statements

823 Followers

CNS Pharmaceuticals Financial Overview

CNS Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-174.042; its P/E ratio is >-0.01; CNS Pharmaceuticals is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.37M$ -4.52M$ -4.02M$ 4.93M$ -5.50M
EBITDA$ -5.37M$ -4.52M$ -4.02M$ 4.93M$ -5.17M
Net Income Common Stockholders$ -5.38M$ -4.52M$ -4.02M$ 4.92M$ -5.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 548.72K$ 909.55K$ 4.28M$ 5.11M$ 10.06M
Total Assets$ 1.70M$ 2.33M$ 6.45M$ 7.41M$ 13.05M
Total Debt$ 300.81K$ 41.90K$ 166.40K$ 289.07K$ 409.97K
Net Debt$ -247.91K$ -867.64K$ -4.11M$ -4.82M$ -9.65M
Total Liabilities$ 6.13M$ 4.07M$ 4.00M$ 3.92M$ 4.92M
Stockholders Equity$ -4.43M$ -1.74M$ 2.45M$ 3.49M$ 8.13M
Cash Flow-
Free Cash Flow$ -2.54M$ -3.38M$ -3.40M$ -4.82M$ -2.31M
Operating Cash Flow$ -2.54M$ -3.38M$ -3.40M$ -4.82M$ -2.31M
Investing Cash Flow$ -2.16K$ -1.74K--$ 1.00
Financing Cash Flow$ 2.18M$ 8.36K$ 2.57M$ -120.28K$ 5.33M
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

CNS Pharmaceuticals Debt to Assets

CNS Pharmaceuticals Cash Flow

CNS Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis